01481nas a2200541   4500000000100000008004100001260001300042653001200055653002600067653001800093653001600111653001600127653001500143653002700158653003100185653001900216653003200235653001100267653001400278653002600292653001200318653001600330653001200346653000900358653002900367653003100396653001200427653001600439653002400455653000900479653001500488653002800503653000900531653003000540653002600570653002900596653002600625653001700651653001000668653002600678653002000704653001700724100001600741245015000757300001100907490000700918022001400925       1970                            d  c1970 May10aAnimals10aAntitubercular Agents10aAspergillosis10aCandidiasis10aChloroquine10aCricetinae10aDisease Models, Animal10aDrug Resistance, Microbial10aDrug Synergism10aEscherichia coli Infections10aFemale10aIsoniazid10aKlebsiella Infections10aleprosy10aListeriosis10aMalaria10aMice10aMycobacterium Infections10aMycobacterium tuberculosis10aMycoses10aNitrofurans10aNocardia Infections10aOils10aPhenazines10aPneumococcal Infections10aRats10aStaphylococcal Infections10aStimulation, Chemical10aStreptococcal Infections10aSurface-Active Agents10aTime Factors10aTinea10aToxoplasmosis, Animal10aTrypanosomiasis10aTuberculosis1 aVischer W A00aAntimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).  a714-230 v20  a0004-4172